SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-014778
Filing Date
2022-05-23
Accepted
2022-05-23 16:01:11
Documents
66
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1639058
2 ex4-1.htm EX-4.1 79482
3 ex4-2.htm EX-4.2 85372
4 ex10-1.htm EX-10.1 237141
5 ex31-1.htm EX-31.1 17705
6 ex31-2.htm EX-31.2 17769
7 ex32-1.htm EX-32.1 11123
  Complete submission text file 0001493152-22-014778.txt   8478427

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE ther-20220331.xsd EX-101.SCH 64306
9 XBRL CALCULATION FILE ther-20220331_cal.xml EX-101.CAL 72028
10 XBRL DEFINITION FILE ther-20220331_def.xml EX-101.DEF 307721
11 XBRL LABEL FILE ther-20220331_lab.xml EX-101.LAB 513076
12 XBRL PRESENTATION FILE ther-20220331_pre.xml EX-101.PRE 388231
60 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1188419
Mailing Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820
Business Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820 225-578-7555
THERALINK TECHNOLOGIES, INC. (Filer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-52218 | Film No.: 22951493
SIC: 2834 Pharmaceutical Preparations